Fact checked byJohn C. Schoen, MA

Read more

January 19, 2024
1 min read
Save

Top in allergy/asthma: Phone screen protector triggers allergy; Q&A on Flovent generics

Fact checked byJohn C. Schoen, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

After a woman developed a rash on her face and fingers several times, her doctors discovered the cause was her cell phone, specifically the acrylate screen protector on her cell phone.

“This is something that’s not commonly seen, but it may be something that’s been missed,” Mohammad A. Younus, MD, an allergist and immunologist at the Center for Allergy, Asthma and Immune Disorders at Hackensack University Medical Center, told Healio. “We really don’t think about acrylates and screen protectors.”

PC0124AllergyListicle_19_Graphic_01
A poster presented at a recent meeting detailed a case involving a woman who experienced repeated onset of contact dermatitis — researchers determined that she was allergic to the acrylate screen protector of her cell phone. Image: Adobe Stock

It was the top story in allergy/asthma last week.

Another top story was a conversation with Angela Duff Hogan, MD, FAAAAI, FACAAI, FAAP, chair of the asthma committee of the American College of Allergy, Asthma and Immunology, about the patients’ options since GSK stopped manufacturing the Flovent HFA and Flovent Diskus fluticasone propionate inhalers and moved to generic production instead.

Read these and more top stories in allergy/asthma below:

Cell phone screen protector triggers allergic contact dermatitis

A woman who used an acrylate screen protector on her cell phone developed a rash on her face and fingers, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting. Read more.

Q&A: Asthma patients have options as GSK moves Flovent to generic production

GSK has stopped manufacturing its Flovent HFA and Flovent Diskus fluticasone propionate inhalers for asthma and has made authorized identical generic versions of these devices available instead. Read more.

Q&A: Epinephrine nasal spray may overcome autoinjector limitations

An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global. Read more.

Peanut-induced FPIES cases increase at pediatric allergy clinic

Cases of food protein-induced enterocolitis syndrome induced by peanuts increased at a pediatric allergy practice between 2015 and 2023, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Read more.

Q&A: Fundraising campaign scores $1 million for food allergy research, education

Food Allergy Research & Education concluded its 2023 fundraising campaign for its research and education efforts with more than $1 million. Read more.